Hermann Reichenspurner

Summary

Affiliation: University of Hamburg
Country: Germany

Publications

  1. ncbi Overview of tacrolimus-based immunosuppression after heart or lung transplantation
    Hermann Reichenspurner
    Department of Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany
    J Heart Lung Transplant 24:119-30. 2005
  2. ncbi Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses
    Moritz Seiffert
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Germany
    J Thorac Cardiovasc Surg 143:617-24. 2012
  3. ncbi Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprostheses
    Moritz Seiffert
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    JACC Cardiovasc Interv 5:341-9. 2012
  4. ncbi Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve
    Hendrik Treede
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    J Thorac Cardiovasc Surg 140:897-903. 2010
  5. ncbi FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy
    Sonja Schrepfer
    University Heart Center, University Hospital Hamburg Eppendorf, Hamburg, Germany
    J Heart Lung Transplant 26:70-7. 2007
  6. ncbi Sirolimus and FK778: a comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway disease
    Tobias Deuse
    Department of Cardiovascular Surgery, University Heart Center, University Hospital Hamburg-Eppendorf, Martinistr, Germany
    Transpl Int 19:310-8. 2006
  7. ncbi Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?
    Sonja Schrepfer
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    Cardiology 108:128-37. 2007
  8. ncbi FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival
    Sonja Schrepfer
    Department of Cardiovascular Surgery, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Transpl Int 18:215-20. 2005
  9. ncbi Impact of MitraClip™ therapy on secondary mitral valve surgery in patients at high surgical risk
    Lenard Conradi
    Department of Cardiovascular Surgery, University Heart Center Hamburg, University Medical Center Hamburg Eppendorf, Martinistr 52, D 20246 Hamburg, Germany
    Eur J Cardiothorac Surg 40:1521-6. 2011
  10. ncbi FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation
    Tobias Deuse
    Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    J Heart Lung Transplant 24:1844-54. 2005

Detail Information

Publications77

  1. ncbi Overview of tacrolimus-based immunosuppression after heart or lung transplantation
    Hermann Reichenspurner
    Department of Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany
    J Heart Lung Transplant 24:119-30. 2005
    ..In particular, the lesser propensity of tacrolimus to cause hypertension and hyperlipidemia potentially offers decreased cardiovascular risk for heart and lung transplant recipients...
  2. ncbi Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses
    Moritz Seiffert
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Germany
    J Thorac Cardiovasc Surg 143:617-24. 2012
    ..Nevertheless, hemodynamic performance is limited by the previously implanted xenograft. We report our experience with patient-prosthesis mismatch (PPM) after valve-in-valve implantation in the aortic position...
  3. ncbi Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprostheses
    Moritz Seiffert
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    JACC Cardiovasc Interv 5:341-9. 2012
    ..This study reports the results of a series of transapical mitral valve-in-valve implantations and aims to offer guidance on technical aspects of the procedure...
  4. ncbi Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve
    Hendrik Treede
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    J Thorac Cardiovasc Surg 140:897-903. 2010
    ..The Direct Flow Medical aortic valve (Direct Flow Medical, Inc, Santa Rosa, Calif) is a nonmetallic tissue valve prosthesis intended to treat patients with severe aortic stenosis at high risk for surgery...
  5. ncbi FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy
    Sonja Schrepfer
    University Heart Center, University Hospital Hamburg Eppendorf, Hamburg, Germany
    J Heart Lung Transplant 26:70-7. 2007
    ..This study examines the efficacy of FK778 regimens for prevention of different phases of xenograft rejection...
  6. ncbi Sirolimus and FK778: a comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway disease
    Tobias Deuse
    Department of Cardiovascular Surgery, University Heart Center, University Hospital Hamburg-Eppendorf, Martinistr, Germany
    Transpl Int 19:310-8. 2006
    ..The anti-proliferative potency on SMCs seems to be an especially important mechanism for FK778. De novo combination regimens revealed no beneficial interaction and thus remain doubtful...
  7. ncbi Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?
    Sonja Schrepfer
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    Cardiology 108:128-37. 2007
    ..To investigate the efficacy of the malononitrilamide FK778 to prevent vascular smooth muscle cell (SMC) migration/proliferation, and vascular fibrosis, the key events in restenosis development using in vivo and in vitro studies...
  8. ncbi FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival
    Sonja Schrepfer
    Department of Cardiovascular Surgery, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Transpl Int 18:215-20. 2005
    ..Therefore, FK778 is a novel, highly desirable immunosuppressive drug for transplantation medicine...
  9. ncbi Impact of MitraClip™ therapy on secondary mitral valve surgery in patients at high surgical risk
    Lenard Conradi
    Department of Cardiovascular Surgery, University Heart Center Hamburg, University Medical Center Hamburg Eppendorf, Martinistr 52, D 20246 Hamburg, Germany
    Eur J Cardiothorac Surg 40:1521-6. 2011
    ..We report our experience with failed MitraClip™ therapy and its impact on subsequent surgical strategies, such as the feasibility of MVR in high-risk patients...
  10. ncbi FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation
    Tobias Deuse
    Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    J Heart Lung Transplant 24:1844-54. 2005
    ..The anti-proliferative potency of FK778 on SMC may be an important mechanism of action. Combination regimens showed favorable drug interaction and allowed dose reduction of both agents to achieve maximal immunosuppressive efficacy...
  11. ncbi A heart team's perspective on interventional mitral valve repair: percutaneous clip implantation as an important adjunct to a surgical mitral valve program for treatment of high-risk patients
    Hendrik Treede
    Department of Cardiovascular Surgery, University Heart Center, Hamburg, Germany
    J Thorac Cardiovasc Surg 143:78-84. 2012
    ..We sought to assess the feasibility of catheter-based mitral valve repair using a clip-based percutaneous edge-to-edge repair system in selected patients at high surgical risk with mitral regurgitation grade 3 or worse...
  12. ncbi The phytoestrogen biochaninA weakens acute cardiac allograft rejection without affecting the reproductive system
    Sonja Schrepfer
    Department of Cardiovascular Surgery, University Hospital Hamburg Eppendorf, Martinistr 52, D 20246 Hamburg, Germany
    Transpl Immunol 15:45-53. 2005
    ....
  13. ncbi Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position
    Moritz Seiffert
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Germany
    Catheter Cardiovasc Interv 76:608-15. 2010
    ..We report our experience with transcatheter valve-in-valve implantations in patients with degenerated bioprostheses in aortic and mitral position...
  14. ncbi Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery
    Volker Rudolph
    Department of General and Interventional Cardiology, University Heart Center, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Am Coll Cardiol 58:2190-5. 2011
    ..The aim of this study was to assess the outcomes of patients at prohibitive surgical risk undergoing MitraClip therapy (Abbott Vascular, Redwood City, California) for severe mitral regurgitation (MR)...
  15. ncbi Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545
    Tobias Deuse
    Transplant and Stem Cell Immunobiology Laboratory, University Heart Center Hamburg, Hamburg, Germany
    Transplantation 94:695-702. 2012
    ..This is the first report on the novel Janus kinase (JAK)1/3 inhibitors R507 and R545 for prevention of acute allograft rejection...
  16. ncbi Transcatheter aortic valve implantation versus surgical aortic valve replacement: a propensity score analysis in patients at high surgical risk
    Lenard Conradi
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    J Thorac Cardiovasc Surg 143:64-71. 2012
    ..In this propensity-score analysis we compared outcomes after TAVI to those after surgical aortic valve replacement (AVR)...
  17. ncbi Comparison of aortic root replacement in patients with Marfan syndrome
    Alexander M J Bernhardt
    Department of Cardiovascular Surgery, University Heart Center, Hamburg, Germany
    Eur J Cardiothorac Surg 40:1052-7. 2011
    ....
  18. ncbi Predictors of outcome of mitral valve prolapse in patients with the Marfan syndrome
    Meike Rybczynski
    Centre of Cardiology and Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany
    Am J Cardiol 107:268-74. 2011
    ..In conclusion, the same clinical determinants that predict outcomes in idiopathic mitral valve prolapse also predict outcomes in mitral valve prolapse associated with Marfan syndrome...
  19. ncbi The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependent
    Tobias Deuse
    Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    Transplantation 77:509-13. 2004
    ..CONCLUSIONS: This study provides evidence that FK778 and tacrolimus show supportive interaction in their immunosuppressive potency that is synergistic in low-dose combinations and additive in higher doses...
  20. ncbi First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention
    Lenard Conradi
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Martinistrasse 52, Hamburg, Germany
    Clin Res Cardiol 100:311-6. 2011
    ..We investigated our experience with combined transcatheter aortic valve implantation (TAVI) and percutaneous coronary intervention (PCI) as an alternative strategy in high-risk patients...
  21. ncbi Midterm stability and hemodynamic performance of a transfemorally implantable nonmetallic, retrievable, and repositionable aortic valve in patients with severe aortic stenosis. Up to 2-year follow-up of the direct-flow medical valve: a pilot study
    Klaudija Bijuklic
    Medical Care Center Prof Mathey, Prof Schofer, Hamburg University Cardiovascular Center, Hamburg University Heart Center, and Radiologische Allianz, Hamburg, Germany
    Circ Cardiovasc Interv 4:595-601. 2011
    ..We, therefore, analyzed the midterm stability of the position, shape, and hemodynamic performance of the DFM percutaneous aortic valve...
  22. ncbi Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction
    Olaf Franzen
    Department of General and Interventional Cardiology, University Heart Centre, Hamburg, Germany
    Eur Heart J 31:1373-81. 2010
    ..We sought to assess the feasibility of catheter-based mitral valve repair using the MitraClip system in high-surgical-risk patients with mitral regurgitation (MR) > or =grade 3+...
  23. ncbi The selective estrogen receptor-beta agonist biochanin A shows vasculoprotective effects without uterotrophic activity
    Sonja Schrepfer
    Department of Cardiovascular Surgery, University Hospital Hamburg Eppendorf, Martinistr, 52, 20246 Hamburg, Germany
    Menopause 13:489-99. 2006
    ....
  24. ncbi Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation
    Hendrik Treede
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Martinistrasse 52, Hamburg, Germany
    J Heart Lung Transplant 31:797-804. 2012
    ..In this study we assessed the efficacy and safety of two de novo immunosuppression protocols to prevent BOS...
  25. ncbi Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients
    Sven Meyer
    Department of General and Interventional Cardiology, University Heart Center, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Transplantation 91:1031-5. 2011
    ..Vaccination against the novel influenza A (H1N1) virus has generally been advocated. There is limited experience with AS03-adjuvanted A/H1N1 pandemic influenza vaccines in immunosuppressed patients...
  26. ncbi FK778 attenuates lymphocyte-endothelium interaction after cardiac transplantation: in vivo and in vitro studies
    Tobias Deuse
    Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    Transplantation 78:71-7. 2004
    ..CONCLUSION: Besides its inhibitory effect on pyrimidine synthesis, FK778 directly reduces endothelial adhesion molecule upregulation and attenuates lymphocyte-endothelium interaction, which is a critical step in graft rejection...
  27. ncbi Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study
    Joachim Schofer
    Medical Care Center Prof Mathey, Prof Schofer and Hamburg University Cardiovascular Center, University Heart Center Hamburg, Hamburg, Germany
    Circ Cardiovasc Interv 1:126-33. 2008
    ....
  28. ncbi Identification and characterization of cells with high angiogenic potential and transitional phenotype in calcific aortic valve
    Fariba Chalajour
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Martinistr 52, Hamburg, Germany
    Exp Cell Res 313:2326-35. 2007
    ..Hence, our findings might provide new insights into the process of pathological angiogenesis in cardiac valves...
  29. ncbi Angiogenic activation of valvular endothelial cells in aortic valve stenosis
    Fariba Chalajour
    Department of Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany
    Exp Cell Res 298:455-64. 2004
    ..These data provide new insights into the mechanisms of valvular disorders and open new perspectives for prevention and early treatment of calcified aortic stenosis...
  30. ncbi Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience
    Ali Aydin
    Department of Electrophysiology, University Heart Center, Hamburg, Germany
    Circ Arrhythm Electrophysiol 5:913-9. 2012
    ..Recently, subcutaneous implantable cardioverter-defibrillator (S-ICD) has become available. The aim of our study was to assess the efficacy of S-ICD in a clinical setting...
  31. ncbi Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?
    Tobias Deuse
    University Heart Center Hamburg, Department of Cardiovascular Surgery, Martinistr 52, 20246, Hamburg, Germany
    Transpl Immunol 17:255-61. 2007
    ..Here we describe the techniques of heterotopic and orthotopic tracheal transplantations in the rat, comparing the kinetics of systemic host immune response and of histopathologic OAD development...
  32. ncbi MitraClip® therapy in patients with end-stage systolic heart failure
    Olaf Franzen
    Department of General and Interventional Cardiology, University Heart Centre, Hamburg, Germany
    Eur J Heart Fail 13:569-76. 2011
    ..To assess the feasibility, short-term durability and clinical outcomes of MitraClip® therapy for mitral regurgitation (MR) in patients with end-stage heart failure and a severely reduced left ventricular (LV) ejection fraction...
  33. ncbi [3-year results of the SYNTAX trial--stent or surgery? A surgeon's perspective]
    Lenard Conradi
    Klinik und Poliklinik für Herz und Gefäßchirurgie, Universitäres Herzzentrum Hamburg, Martinistrasse 52, Hamburg, Germany
    Clin Res Cardiol Suppl 6:43-8. 2011
    ..Final decision making should be a formal process as recommended in the recently updated guidelines on myocardial revascularization by the European Society of Cardiology...
  34. ncbi Asymptomatic infection with novel influenza A/H1N1 virus in a heart transplant recipient
    Sven Meyer
    Department of General and Interventional Cardiology, University Heart Center, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Heart Lung Transplant 29:585-6. 2010
    ..We present the first case of a young heart transplant recipient who remained asymptomatic despite positive polymerase chain reaction (PCR) after exposure to individuals with influenza A/H1N1...
  35. ncbi Surgical technique of lower lobe lung transplantation
    Tobias Deuse
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    Ann Thorac Surg 92:e39-42. 2011
    ..Here we describe our surgical technique and discuss the benefits and risks of this procedure...
  36. ncbi Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment
    Eberhard Schulz
    University Hospital Eppendorf, Division of Cardiology, Hamburg, Germany
    Circulation 105:1170-5. 2002
    ..CONCLUSIONS: We conclude that long-term NTG treatment induces endothelial dysfunction and impaired vascular NO/cGMP signaling in humans, which can be monitored by measuring P-VASP levels...
  37. ncbi Evaluation of acute traumatic changes of the coronary artery wall after robotically assisted endoscopic coronary artery bypass grafting
    Martin Arnold
    Department of Cardiac Surgery, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Heart Surg Forum 5:128-31. 2002
    ..Goleta, CA) in a laboratory setting...
  38. ncbi How to guide stent-graft implantation in type B aortic dissection? Comparison of angiography, transesophageal echocardiography, and intravascular ultrasound
    Dietmar H Koschyk
    Department of Cardiology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Circulation 112:I260-4. 2005
    ..Despite growing interest in stent-graft implantation for type-B aortic dissection, there are no established recommendations to prepare and perform an implantation procedure...
  39. ncbi Minimally invasive direct coronary artery bypass grafting (MIDCAB) and off-pump coronary artery bypass grafting (OPCAB): two techniques for beating heart surgery
    Christian Detter
    Department of Cardiac Surgery, University Hospital Grosshadern, Ludwig Maximilian University, Munich, Germany
    Heart Surg Forum 5:157-62. 2002
    ..Coronary bypass surgery can be performed less invasively by avoiding cardiopulmonary bypass (CPB). We present our experiences with beating heart bypass surgery performed through a minithoracotomy or sternotomy...
  40. ncbi Robotically-assisted coronary artery surgery with and without cardiopulmonary bypass - from first clinical use to endoscopic operation
    Christian Detter
    Department of Thoracic and Cardiovascular Surgery, University Hospital Grosshadern, Munich, Germany
    Med Sci Monit 8:MT118-23. 2002
    ..Recently, the ZEUS(tm) Robotic Surgical System has been introduced to increase the precision of endoscopic cardiac surgery. This study investigated its clinical use for endoscopic coronary artery bypass grafting...
  41. ncbi Comparison of two stabilizer concepts for off-pump coronary artery bypass grafting
    Christian Detter
    Department of Cardiac Surgery, University Hospital Grosshadern, Ludwig Maximilian University, Munich, Germany
    Ann Thorac Surg 74:497-501. 2002
    ..This study was designed to evaluate the efficacy of two different stabilizer concepts for off-pump coronary artery bypass grafting...
  42. ncbi New technique for chest opening in mice: U-sternotomy
    Sonja Schrepfer
    Department of Thoracic and Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany
    Microsurgery 23:274-5. 2003
    ..This U-sternotomy reduces the risk of animal death and therefore the amount of quite expensive virus solutions needed...
  43. ncbi Multidetector computed tomography (MDCT) in coronary surgery: first experiences with a new tool for diagnosis of coronary artery disease
    Hendrik Treede
    Department of Cardiac Surgery, Ludwig Maximilians University Munich, Germany
    Ann Thorac Surg 74:S1398-402. 2002
    ..Patients underwent CT scans in addition to SCA; findings were compared regarding location and degree of coronary artery stenosis...
  44. ncbi Minimally invasive valve surgery: different techniques and approaches
    Christian Detter
    Department of Cardiovascular Surgery, University Hospital Hamburg Eppendorf, Martinistr 52, D 20246 Hamburg, Germany
    Expert Rev Cardiovasc Ther 2:239-51. 2004
    ..This article will review the different minimally invasive techniques and approaches, as well as early results and outcomes for aortic and mitral valve surgery...
  45. ncbi Experimental orthotopic tracheal transplantation: The Stanford technique
    Sonja Schrepfer
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305 5407, USA
    Microsurgery 27:187-9. 2007
    ..The technique is easy to learn, the procedure is well tolerated by the animals, and the grafts develop OAD lesions similar to those of human obliterative bronchiolitis...
  46. ncbi Concomitant transcatheter aortic valve and left ventricular assist device implantation
    Christina Baum
    University Heart Center Hamburg, 20246 Hamburg, Germany
    ASAIO J 59:90-2. 2013
    ..We believe concomitant transcatheter aortic valve implantation (TAVI) and LVAD implantation is a promising hybrid procedure, even in patients with pure AR...
  47. ncbi Prospective, randomized study comparing two different minimized versus conventional cardiopulmonary bypass systems
    Jeannette Schoenebeck
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    Innovations (Phila) 5:270-7. 2010
    ..We aimed to assess the impact of two different minimized cardiopulmonary bypass systems (mini-CPB) with and without Bioline-coating compared with CCPB regarding organ function, inflammatory response, and early clinical outcome...
  48. ncbi Spontaneous coronary bypass rupture
    Jan Kaehler
    Department of Cardiology, University Hospital Hamburg, Hamburg, Germany
    Ann Thorac Surg 86:664. 2008
  49. ncbi Fluorescent cardiac imaging: a novel intraoperative method for quantitative assessment of myocardial perfusion during graded coronary artery stenosis
    Christian Detter
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Martinistr 52, D 20246 Hamburg, Germany
    Circulation 116:1007-14. 2007
    ..FCI is a novel technology to visualize coronary vessels and myocardial perfusion intraoperatively using the indocyanine green dye with an infrared-sensitive imaging device...
  50. ncbi Successful extracorporeal membrane oxygenation weaning after cardiac resynchronization therapy device implantation in a patient with end-stage heart failure
    Simon Pecha
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    Interact Cardiovasc Thorac Surg 15:922-3. 2012
    ..We decided to proceed with CRT-D implantation while still on ECMO support. With biventricular stimulation, cardiac function improved promptly and the patient could be weaned from ECMO the same day...
  51. ncbi Impact of AT2 receptor deficiency on postnatal cardiovascular development
    Daniel Biermann
    Department of Cardiovascular Surgery, University Heart Center, Hamburg, Germany
    PLoS ONE 7:e47916. 2012
    ..The angiotensin II receptor subtype 2 (AT2 receptor) is ubiquitously and highly expressed in early postnatal life. However, its role in postnatal cardiac development remained unclear...
  52. ncbi Use of initial biventricular mechanical support in a case of postinfarction ventricular septal rupture as a bridge to surgery
    Lenard Conradi
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    Ann Thorac Surg 87:e37-9. 2009
    ..This approach may represent a new treatment option restoring hemodynamic stability and avoiding surgery on freshly infarcted myocardium...
  53. ncbi Coincidence of aortic valve stenosis and regurgitation and multiple cardiac papillary fibroelastomas in a young male adult
    Karsten Sydow
    Department of Cardiology, Hamburg University Heart Center, Hamburg, Germany
    J Thorac Cardiovasc Surg 133:564-5. 2007
  54. ncbi Vascular wall resident progenitor cells: a source for postnatal vasculogenesis
    Elvin Zengin
    Center of Experimental Medicine, Institute of Anatomy I, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    Development 133:1543-51. 2006
    ....
  55. ncbi Gender effects on health care costs in cardiovascular medicine-a black box?
    Helmut Gulbins
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    Thorac Cardiovasc Surg 61:74-8. 2013
    ..This manuscript deals with the possible economic implications of gender-related differences in cardiovascular medicine...
  56. ncbi Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model
    Tobias Deuse
    Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Germany
    Transplantation 76:1627-9. 2003
    ..3 +/- 2.9 days; P<0.01; combination index=0.85). High-dose drug combination (mean survival time 24.0 +/- 1.4 days) showed antagonistic drug interaction (combination index=1.55) with increased toxic side effects...
  57. ncbi Frequency and age-related course of mitral valve dysfunction in the Marfan syndrome
    Meike Rybczynski
    Centre of Cardiology and Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany
    Am J Cardiol 106:1048-53. 2010
    ..006). In conclusion, MVP was comparatively frequent in patients with the Marfan syndrome and carries an increased risk of progression to severe MVR and endocarditis, especially in older adults...
  58. ncbi Video and robotic-assisted minimally invasive mitral valve surgery: a comparison of the Port-Access and transthoracic clamp techniques
    Hermann Reichenspurner
    Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    Ann Thorac Surg 79:485-90; discussion 490-1. 2005
    ..The MICRO technique tends to shorten the time of surgery and aortic cross-clamping and reduces perioperative costs by simplifying the operative procedure...
  59. ncbi Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation
    Volker Rudolph
    1Department of General and Interventional Cardiology and Cardiovascular Research Center, University Heart Center, Hamburg, Germany
    Nat Med 16:470-4. 2010
    ..Our data demonstrate that MPO is a crucial prerequisite for structural remodeling of the myocardium, leading to an increased vulnerability to atrial fibrillation...
  60. ncbi Which patients benefit from stentless aortic valve replacement?
    Helmut Gulbins
    Department of Cardiovascular Surgery, University Heart Center, University Hospital Eppendorf, Hamburg, Germany
    Ann Thorac Surg 88:2061-8. 2009
    ..Jude Medical, Minneapolis, MN) showed an increase in degeneration after 10 years of follow-up, whereas the Freestyle porcine stentless prostheses (Medtronic, Minneapolis, MN) still showed excellent results after this period...
  61. ncbi The MLCK-mediated alpha1-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signaling
    Michael Grimm
    Institute of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, Hamburg, Germany
    Br J Pharmacol 148:991-1000. 2006
    ....
  62. ncbi Successful resection of a symptomatic right ventricular lipoma
    Sonja Schrepfer
    Department of Cardiovascular Surgery, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Ann Thorac Surg 76:1305-7. 2003
    ..Histology confirmed diagnosis of a benign cardiac lipoma. The postoperative course was uneventful and the patient was discharged 7 days after surgery. There was no episode of ventricular tachycardias during the 6-month follow-up...
  63. ncbi Robotically assisted coronary artery bypass surgery with the ZEUS telemanipulator system
    Dieter H Boehm
    Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    Semin Thorac Cardiovasc Surg 15:112-20. 2003
    ..This article summarizes the current worldwide experience with the ZEUS(TM) system in cardiac surgery and describes the steps from preclinical to endoscopic operation, focusing on the potential limitations of the procedure and the system...
  64. ncbi Stent-based approach for ventricle-to-coronary artery bypass
    Peter Boekstegers
    Department of Internal Medicine I, Grosshadern University Hospital, Munich, Germany
    Circulation 106:1000-6. 2002
    ..Ventricle-to-coronary artery bypass (VCAB) is an experimental revascularization procedure that provides predominantly systolic instead of diastolic blood flow to a coronary artery...
  65. ncbi Myoblasts survive intracardiac transfer and divide further after transplantation
    Helmut Gulbins
    Department of Cardiac Surgery, University Hospital Grosshadern, LMU Munich, D 81366 Munich, Germany
    Heart Surg Forum 5:340-4. 2002
    ..In addition, an intravital fluorescence dye for marking these cells was evaluated...
  66. ncbi Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial
    Andreas Zuckermann
    Department of Cardiothoracic Surgery, University of Vienna, Austria
    J Thorac Cardiovasc Surg 125:891-900. 2003
    ..Benefit or risk deriving from the combination with mycophenolate mofetil are yet unknown...
  67. ncbi Early and midterm results after coronary artery bypass grafting with and without cardiopulmonary bypass: which patient population benefits the most?
    Tobias Deuse
    Department of Cardiac Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Germany
    Heart Surg Forum 6:77-83. 2003
    ..We present our early and midterm results with off-pump coronary artery bypass grafting (OPCAB) on the beating heart and with conventional coronary artery bypass grafting (CABG) and compare patient outcomes for both procedures...
  68. ncbi Retroinfusion-supported stenting in high-risk patients for percutaneous intervention and bypass surgery: results of the prospective randomized myoprotect I study
    Tilmann Pohl
    Department of Internal Medicine I, Grosshadern University Hospital, Munich, Germany
    Catheter Cardiovasc Interv 62:323-30. 2004
    ....
  69. ncbi International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection
    Kambiz Sarahrudi
    Department of Cardithoracic Surgery, University of Vienna, Austria
    J Thorac Cardiovasc Surg 127:1126-32. 2004
    ..Conversion for bronchiolitis obliterans syndrome allows short-term stabilization of lung function in most patients...
  70. ncbi [Mitral valve reconstruction without cardiopulmonary bypass. Border zone between cardiac surgery and interventional cardiology]
    Thilo Tübler
    Universitäres Herz und Gefässzentrum Hamburg GmbH, Hamburg
    Herz 31:406-12. 2006
    ..In this article, the authors focus on the available data as well as on the advantages and disadvantages of the different approaches...
  71. ncbi Review on balloon aortic valvuloplasty: a surgeon's perspective in 2008
    Lenard Conradi
    Clin Res Cardiol 97:285-7. 2008
    ..In the rare case of real contraindications to surgical AVR transcatheter valve implantation techniques seem to be the more adequate alternative today...
  72. ncbi Improved results after heart-lung transplantation: a 17-year experience
    Bruno Reichart
    Department of Cardiac Surgery, University Hospital Grosshadern, Ludwigs-Maximilians-University, Munich, Germany
    Transplantation 75:127-32. 2003
    ..Long-term results can only be improved in cases of successful prevention and treatment of OB...
  73. ncbi Diagnosis of perioperative myocardial infarction after coronary artery bypass surgery
    Hermann Reichenspurner
    Herz 29:656-7. 2004
  74. ncbi [Myoblasts from the leg into the heart: can infarct damage be rectified in this manner? (interview by Dr. Judith Neumaier)]
    Hermann Reichenspurner
    MMW Fortschr Med 147:22. 2005
  75. ncbi Heart transplantation: an approach to treating primary cardiac sarcoma?
    Peter Uberfuhr
    Division of Cardiac Surgery, Klinikum Grosshadern, University of Munich, Munich, Germany
    J Heart Lung Transplant 21:1135-9. 2002
    ..However, pre-operative chemotherapy can regress tumors in chemosensitive C-STS and potentially eradicate early micrometastases. Consecutive HTx for responders may then offer a chance of long-term survival...
  76. ncbi The Cardica C-Port System: clinical and angiographic evaluation of a new device for automated, compliant distal anastomoses in coronary artery bypass grafting surgery--a multicenter prospective clinical trial
    Klaus E Matschke
    Department of Cardiac Surgery, University of Technology Dresden, Dresden, Germany
    J Thorac Cardiovasc Surg 130:1645-52. 2005
    ..The goal of this prospective, nonrandomized, and multicenter study is to determine the safety and efficacy of this novel anastomotic system...
  77. ncbi Introducing the first polymer-free leflunomide eluting stent
    Tobias Deuse
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, 300 Pasteur Dr, CVRB MC 5407, Stanford, CA, USA
    Atherosclerosis 200:126-34. 2008
    ..We here describe the pharmacological characteristic, in vivo efficacy, and in vitro mechanisms of a polymer-free leflunomide eluting stent in comparison to its rapamycin-coated equivalent...